BRPI0814835B8 - composição farmacêutica oral de desmopressina e seu uso - Google Patents

composição farmacêutica oral de desmopressina e seu uso

Info

Publication number
BRPI0814835B8
BRPI0814835B8 BRPI0814835A BRPI0814835A BRPI0814835B8 BR PI0814835 B8 BRPI0814835 B8 BR PI0814835B8 BR PI0814835 A BRPI0814835 A BR PI0814835A BR PI0814835 A BRPI0814835 A BR PI0814835A BR PI0814835 B8 BRPI0814835 B8 BR PI0814835B8
Authority
BR
Brazil
Prior art keywords
desmopressin
pharmaceutical composition
oral pharmaceutical
oral
jurgens
Prior art date
Application number
BRPI0814835A
Other languages
English (en)
Inventor
PARENTE DUEÑA Antonio
Boix Montañes Antonio
García Plumed Cesar
Nieto Abad Carlos
Carbajal Navarro Nuria
Mis Vizcaino Ricard
Original Assignee
Gp Pharm Sa
Laboratorio Reig Jofre S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gp Pharm Sa, Laboratorio Reig Jofre S A filed Critical Gp Pharm Sa
Publication of BRPI0814835A2 publication Critical patent/BRPI0814835A2/pt
Publication of BRPI0814835B1 publication Critical patent/BRPI0814835B1/pt
Publication of BRPI0814835B8 publication Critical patent/BRPI0814835B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

composição farmacêutica oral de desmopressina. composição farmacêutica oral e líquida de desmopressina e seu uso para tratamento do diabetes insípido central, enurese primária noturna, hemorragia em pacientes com hemofilia a, com enfermidade de von willebrand-jurgens e hemorragias pós-cirúrgicas.
BRPI0814835A 2007-08-06 2008-08-01 composição farmacêutica oral de desmopressina e seu uso BRPI0814835B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200702215 2007-08-06
ES200702215A ES2319054B1 (es) 2007-08-06 2007-08-06 Composicion farmaceutica oral de desmopresina.
PCT/ES2008/000539 WO2009027561A2 (es) 2007-08-06 2008-08-01 Composición farmacéutica oral de desmopresina

Publications (3)

Publication Number Publication Date
BRPI0814835A2 BRPI0814835A2 (pt) 2015-03-31
BRPI0814835B1 BRPI0814835B1 (pt) 2020-10-27
BRPI0814835B8 true BRPI0814835B8 (pt) 2021-05-25

Family

ID=40032884

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814835A BRPI0814835B8 (pt) 2007-08-06 2008-08-01 composição farmacêutica oral de desmopressina e seu uso

Country Status (18)

Country Link
US (1) US8993521B2 (pt)
EP (1) EP2174652B1 (pt)
JP (1) JP5626682B2 (pt)
CN (2) CN106265494A (pt)
AR (1) AR068337A1 (pt)
BR (1) BRPI0814835B8 (pt)
CY (1) CY1118459T1 (pt)
DK (1) DK2174652T3 (pt)
ES (2) ES2319054B1 (pt)
HR (1) HRP20161676T1 (pt)
HU (1) HUE032667T2 (pt)
LT (1) LT2174652T (pt)
MX (1) MX2010001456A (pt)
PL (1) PL2174652T3 (pt)
PT (1) PT2174652T (pt)
RU (1) RU2474414C2 (pt)
SI (1) SI2174652T1 (pt)
WO (1) WO2009027561A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
EP0381345B1 (en) * 1989-01-30 1994-07-13 Corint, Ltd. Aqueous liquid desmopressin-CMC pharmaceutical composition
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2070061C (en) 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
US5298256A (en) 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
IT1255460B (it) 1992-07-28 1995-11-02 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
SE9300937L (sv) 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
RU2232608C2 (ru) * 1998-11-02 2004-07-20 Элзэ Копэрейшн Устройство для чрескожной доставки лекарственного средства электропереносом и способ его изготовления, способ чрескожной доставки лекарственного средства пациенту электропереносом
US6894026B1 (en) 2000-01-11 2005-05-17 Atossa Healthcare, Inc. Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
EP1121935B1 (en) * 2000-02-04 2008-08-13 Patents Exploitation Company B.V. Pharmaceutical composition containing a small or medium size peptide
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003269747A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
ITMI20021684A1 (it) 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
EA012306B1 (ru) * 2003-01-24 2009-08-28 Магле Холдинг Аб Композиционный материал для доставки через слизистые оболочки
EP1473029B1 (en) 2003-04-30 2005-03-23 Ferring B.V. Solid dosage form comprising desmopressin
ES2243840T3 (es) 2003-07-25 2005-12-01 Ferring B.V. Composicion farmaceutica de desmopresina como forma farmaceutica solida de dosificacion y metodo para la fabricacion de la misma.
CN1878563A (zh) 2003-11-10 2006-12-13 西摩·H·费恩 包含低剂量去氨加压素的药物组合物
GB0406048D0 (en) 2004-03-18 2004-04-21 Ardana Bioscience Ltd Drug formulations
US20050244502A1 (en) 2004-04-28 2005-11-03 Mathias Neil R Composition for enhancing absorption of a drug and method

Also Published As

Publication number Publication date
HUE032667T2 (en) 2017-10-30
BRPI0814835A2 (pt) 2015-03-31
PT2174652T (pt) 2016-12-23
ES2319054B1 (es) 2010-02-12
CY1118459T1 (el) 2017-07-12
WO2009027561A3 (es) 2009-07-16
EP2174652A2 (en) 2010-04-14
WO2009027561A2 (es) 2009-03-05
DK2174652T3 (en) 2017-01-23
RU2474414C2 (ru) 2013-02-10
CN106265494A (zh) 2017-01-04
EP2174652B1 (en) 2016-10-05
JP5626682B2 (ja) 2014-11-19
JP2010535745A (ja) 2010-11-25
AR068337A1 (es) 2009-11-11
RU2010105031A (ru) 2011-09-20
US8993521B2 (en) 2015-03-31
CN101808621A (zh) 2010-08-18
ES2319054A1 (es) 2009-05-01
PL2174652T3 (pl) 2017-06-30
HRP20161676T1 (hr) 2017-02-24
ES2608816T3 (es) 2017-04-17
SI2174652T1 (sl) 2017-04-26
BRPI0814835B1 (pt) 2020-10-27
US20110251123A1 (en) 2011-10-13
MX2010001456A (es) 2010-06-02
LT2174652T (lt) 2017-02-27

Similar Documents

Publication Publication Date Title
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
EA201100958A1 (ru) Фармацевтическая пероральная дозированная лекарственная форма на основе ингибиторов dpp iv
DE602007012354D1 (de) Medizinisches abgabeystem mit drehbarem verschlüsselungselement
CR11478A (es) Toalla para llevar puesta
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
NZ617196A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
CR20110042A (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo [1,4]dioxin-2-ilmetil)-sulfamida
MY173629A (en) Dosage form
PH12013501790B1 (en) Use of dpp iv inhibitors
CL2008001994A1 (es) Compuestos derivados de pirazin-2-ona; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, aterosclerosis, hipertension, entre otras.
CL2008003116A1 (es) Compuestos heterocíclicos bicíclicos; composición farmacéutica que comprende a dichos compuestos; y su uso en el tratamiento o prevención de enfermedades tales como diabetes, obesidad, trastorno metabólico, enfermedad cardiovascular entre otras.
IL197441A (en) @ Polymer @ and @@ box – a @@ hmgb strains or a wild variety or its active biological components, medicinal preparations containing them and their use in the preparation of drugs for the prevention or treatment of related pathologies to @ hmgbA
MX2010001574A (es) Ligandos del receptor cannabinoide.
DE60327693D1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
ECSP045025A (es) Combinación de opioides seleccionados con antagonistas muscarnicos para el tratamiento de la incontinencia urinaria
CL2007002196A1 (es) Compuestos heterociclicos nitrogenados, moduladores de la actividad del receptor de quimioquina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, obesidad, sindrome metabolico y dolor.
BRPI0714811A2 (pt) Modulador de receptor de corticóide, seus sais, composições farmacêuticas compreendendo os mesmos e uso dos referidos compostos e sais na fabricação de medicamento
CL2004000838A1 (es) Uso de un antagonista del receptor de aldosterona y un agente antiobesidad para preparar un medicamento util en el tratamiento de una condicion relacionada al sistema cardiovascular.
MX2007000420A (es) Suplemento de electrolito y metodo de uso.
PA8824601A1 (es) Utilizacion de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia
BRPI0814835B8 (pt) composição farmacêutica oral de desmopressina e seu uso
MY164112A (en) A combination composition comprising ibuprofen and paracetamol
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
GEP20115158B (en) Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
CL2011000252A1 (es) Uso de estriol para preparar un medicamento util en la prevencion y/o el tratamiento de atrofia urogenital en mujeres.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/08/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.